Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0901 CMS devices
BioCentury & Getty Images

Politics, Policy & Law

Proposed CMS pathway could be expanded to give therapies, diagnostics immediate, national coverage

Comments due Nov. 2 on rule seeking to speed reimbursement for breakthrough devices

Read the full 368 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE